News|Articles|November 30, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-12-02-2015
  • Volume 11
  • Issue 12

Instrument Manufacturers Collaborate on Interoperability

Agilent Technologies and Thermo Fisher Scientific exchange instrument control drivers and software support.

Agilent Technologies and Thermo Fisher Scientific announced an agreement on Nov. 5, 2015 to exchange instrument controls to improve the productivity and user experience of customers using the companies software and instruments.

Under this agreement, the companies will exchange instrument-control driver documentation and software for liquid chromatographs, gas chromatographs, capillary electrophoresis, and ion chromatographs. The companies will also provide technical assistance to each other’s software development groups, for control of Agilent instruments in the Thermo Scientific Chromeleon software, and Thermo Scientific instruments in the Agilent OpenLAB CDS software. 

The agreement also defines terms for licensing and redistribution of instrument control software, as well as formal escalation mechanisms to jointly drive technical issue resolution for their mutual customers.

The instrument control exchange agreement reflects the increasing importance of manufacturer collaboration to achieve interoperability and standardization of multivendor instrument control, so that analytical laboratories can increase productivity while minimizing technical and regulatory risks and validation costs, according to a press statement. 

Source: Agilent Technologies


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.